162 related articles for article (PubMed ID: 19685112)
1. Functional analysis of ryanodine receptor type 1 p.R2508C mutation in exon 47.
Migita T; Mukaida K; Hamada H; Yasuda T; Haraki T; Nishino I; Murakami N; Kawamoto M
J Anesth; 2009; 23(3):341-6. PubMed ID: 19685112
[TBL] [Abstract][Full Text] [Related]
2. Several Ryanodine Receptor Type 1 Gene Mutations of p.Arg2508 Are Potential Sources of Malignant Hyperthermia.
Miyoshi H; Yasuda T; Otsuki S; Kondo T; Haraki T; Mukaida K; Nakamura R; Hamada H; Kawamoto M
Anesth Analg; 2015 Oct; 121(4):994-1000. PubMed ID: 26381711
[TBL] [Abstract][Full Text] [Related]
3. Genetic and functional analysis of the RYR1 mutation p.Thr84Met revealed a susceptibility to malignant hyperthermia.
Kondo T; Yasuda T; Mukaida K; Otsuki S; Kanzaki R; Miyoshi H; Hamada H; Nishino I; Kawamoto M
J Anesth; 2018 Apr; 32(2):174-181. PubMed ID: 29344738
[TBL] [Abstract][Full Text] [Related]
4. Mutated p.4894 RyR1 function related to malignant hyperthermia and congenital neuromuscular disease with uniform type 1 fiber (CNMDU1).
Haraki T; Yasuda T; Mukaida K; Migita T; Hamada H; Kawamoto M
Anesth Analg; 2011 Dec; 113(6):1461-7. PubMed ID: 21926372
[TBL] [Abstract][Full Text] [Related]
5. Mutations to Gly2370, Gly2373 or Gly2375 in malignant hyperthermia domain 2 decrease caffeine and cresol sensitivity of the rabbit skeletal-muscle Ca2+-release channel (ryanodine receptor isoform 1).
Du GG; Oyamada H; Khanna VK; MacLennan DH
Biochem J; 2001 Nov; 360(Pt 1):97-105. PubMed ID: 11695996
[TBL] [Abstract][Full Text] [Related]
6. Caffeine and halothane sensitivity of intracellular Ca2+ release is altered by 15 calcium release channel (ryanodine receptor) mutations associated with malignant hyperthermia and/or central core disease.
Tong J; Oyamada H; Demaurex N; Grinstein S; McCarthy TV; MacLennan DH
J Biol Chem; 1997 Oct; 272(42):26332-9. PubMed ID: 9334205
[TBL] [Abstract][Full Text] [Related]
7. Detection of a novel ryanodine receptor subtype 1 mutation (R328W) in a malignant hyperthermia family by sequencing of a leukocyte transcript.
Loke JC; Kraev N; Sharma P; Du G; Patel L; Kraev A; MacLennan DH
Anesthesiology; 2003 Aug; 99(2):297-302. PubMed ID: 12883402
[TBL] [Abstract][Full Text] [Related]
8. Functional characterization of malignant hyperthermia-associated RyR1 mutations in exon 44, using the human myotube model.
Wehner M; Rueffert H; Koenig F; Olthoff D
Neuromuscul Disord; 2004 Jul; 14(7):429-37. PubMed ID: 15210166
[TBL] [Abstract][Full Text] [Related]
9. Functional characterisation of the R2452W ryanodine receptor variant associated with malignant hyperthermia susceptibility.
Roesl C; Sato K; Schiemann A; Pollock N; Stowell KM
Cell Calcium; 2014 Sep; 56(3):195-201. PubMed ID: 25086907
[TBL] [Abstract][Full Text] [Related]
10. Functional defects in six ryanodine receptor isoform-1 (RyR1) mutations associated with malignant hyperthermia and their impact on skeletal excitation-contraction coupling.
Yang T; Ta TA; Pessah IN; Allen PD
J Biol Chem; 2003 Jul; 278(28):25722-30. PubMed ID: 12732639
[TBL] [Abstract][Full Text] [Related]
11. Measurement of resting cytosolic Ca2+ concentrations and Ca2+ store size in HEK-293 cells transfected with malignant hyperthermia or central core disease mutant Ca2+ release channels.
Tong J; McCarthy TV; MacLennan DH
J Biol Chem; 1999 Jan; 274(2):693-702. PubMed ID: 9873004
[TBL] [Abstract][Full Text] [Related]
12. Functional characterization of the RYR1 mutation p.Arg4737Trp associated with susceptibility to malignant hyperthermia.
Johannsen S; Treves S; Müller CR; Mögele S; Schneiderbanger D; Roewer N; Schuster F
Neuromuscul Disord; 2016 Jan; 26(1):21-5. PubMed ID: 26631338
[TBL] [Abstract][Full Text] [Related]
13. Increased sensitivity to 4-chloro-m-cresol and caffeine in primary myotubes from malignant hyperthermia susceptible individuals carrying the ryanodine receptor 1 Thr2206Met (C6617T) mutation.
Wehner M; Rueffert H; Koenig F; Neuhaus J; Olthoff D
Clin Genet; 2002 Aug; 62(2):135-46. PubMed ID: 12220451
[TBL] [Abstract][Full Text] [Related]
14. Effects of caffeine, halothane, and 4-chloro-m-cresol on skeletal muscle lactate and pyruvate in malignant hyperthermia-susceptible and normal swine as assessed by microdialysis.
Bina S; Cowan G; Karaian J; Muldoon S; Mongan P; Bünger R
Anesthesiology; 2006 Jan; 104(1):90-100. PubMed ID: 16394695
[TBL] [Abstract][Full Text] [Related]
15. An autosomal dominant congenital myopathy with cores and rods is associated with a neomutation in the RYR1 gene encoding the skeletal muscle ryanodine receptor.
Monnier N; Romero NB; Lerale J; Nivoche Y; Qi D; MacLennan DH; Fardeau M; Lunardi J
Hum Mol Genet; 2000 Nov; 9(18):2599-608. PubMed ID: 11063719
[TBL] [Abstract][Full Text] [Related]
16. Propofol-induced changes in myoplasmic calcium concentrations in cultured human skeletal muscles from RYR1 mutation carriers.
Migita T; Mukaida K; Kawamoto M; Kobayashi M; Nishino I; Yuget O
Anaesth Intensive Care; 2007 Dec; 35(6):894-8. PubMed ID: 18084979
[TBL] [Abstract][Full Text] [Related]
17. Mutational analysis of putative calcium binding motifs within the skeletal ryanodine receptor isoform, RyR1.
Fessenden JD; Feng W; Pessah IN; Allen PD
J Biol Chem; 2004 Dec; 279(51):53028-35. PubMed ID: 15469935
[TBL] [Abstract][Full Text] [Related]
18. Calcium release from sarcoplasmic reticulum is facilitated in human myotubes derived from carriers of the ryanodine receptor type 1 mutations Ile2182Phe and Gly2375Ala.
Wehner M; Rueffert H; Koenig F; Olthoff D
Genet Test; 2003; 7(3):203-11. PubMed ID: 14641996
[TBL] [Abstract][Full Text] [Related]
19. RYR1 mutations causing central core disease are associated with more severe malignant hyperthermia in vitro contracture test phenotypes.
Robinson RL; Brooks C; Brown SL; Ellis FR; Halsall PJ; Quinnell RJ; Shaw MA; Hopkins PM
Hum Mutat; 2002 Aug; 20(2):88-97. PubMed ID: 12124989
[TBL] [Abstract][Full Text] [Related]
20. Novel double and single ryanodine receptor 1 variants in two Austrian malignant hyperthermia families.
Kaufmann A; Kraft B; Michalek-Sauberer A; Weindlmayr M; Kress HG; Steinboeck F; Weigl LG
Anesth Analg; 2012 May; 114(5):1017-25. PubMed ID: 22415532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
